- News & events
- About us
- Contact us
- Somers Research Group
- Faculty and Staff Resources
- 1 778 782-9691
- BLU 9704
Areas of interest
Mechanisms of viral pathogenesis and antiviral discovery
- BA, Molecular Biology, University of Pennsylvania
- PhD, Biochemistry, Harvard University
Dr. Ian Tietjen joined the Faculty of Health Sciences in July 2017. Previously he was a visiting Postdoctoral Fellow with Dr. Charles Rice at Rockefeller University and a Research Associate with Drs. Zabrina Brumme and Mark Brockman at FHS and Dr. David Fedida at the University of British Columbia. He also worked as a Group Leader in Molecular and Cellular Biology at Cardiome Pharma Corp. in Vancouver, BC and a Senior Scientist at Xenon Pharmaceuticals in Burnaby, BC.
Dr. Tietjen’s research focuses on mechanisms of viral pathogenesis and antiviral discovery. His laboratory uses cell biology, genetics, and drug discovery techniques to investigate the molecular properties of HIV latency and replication of flaviviruses such as yellow fever and Zika. Dr. Tietjen’s laboratory also conducts screens of chemical compound libraries, natural products, and traditional medicines to identify and characterize new antivirals. Dr. Tietjen is also interested in documenting and investigating natural product and traditional medicine-based antivirals used in Southern Africa, Canada, and elsewhere.
Dr. Tietjen’s teaching interests include virology, genetics, molecular and cell biology, and biotechnology. Dr. Tietjen is currently accepting students at all degree levels. Students interested in joining the lab should contact him at email@example.com.
Future courses may be subject to change.
Publications and activities
View Dr. Tietjen's publications here.